The international team from the Peter Doherty Institute for Infection and Immunity were able to figure out how to repurpose a molecule called PBT2 and use it to break bacterial resistance to commonly used frontline antibiotics. The PBT2 molecule was originally developed as a potential treatment for disorders such as Alzheimer’s, Parkinson’s and Huntington’s diseases. […]